MetLife (MET) In-Depth Stock Report
A global life-and-benefits insurer executing a New Frontier strategy focused on Group Benefits, Retirement, Asia, and disciplined capital return.
Investment Summary
Every headline number this report produces, collected in one place before the analysis that derives them. All figures are computed live at page load, so this block reflects the market as of the moment you opened the page.
- Group Benefits stability.
- PRT activity supports RIS.
- Interest rate environment favorable.
- Consistent capital return.
- MET is a diversified life-and-benefits insurer with disciplined capital return.
- Group Benefits and PRT anchor; Asia provides growth with FX volatility.
- Four segments: Group Benefits, Retirement & Income Solutions (RIS), Asia, Latin America.
- US Group Benefits is a scale leader in employee-benefits distribution.
- RIS is exposed to pension risk transfer (PRT) — a growing institutional market.
- Asia exposure (Japan, Korea, China) provides growth optionality with FX volatility.
- Consistent dividend and buyback program.
Executive Summary
MetLife executes a diversified life-and-benefits model with meaningful global exposure and a disciplined capital-return posture.
Group Benefits is the most stable earnings segment and a core competitive strength in the US.
RIS benefits from pension risk transfer activity, which has been robust.
Asia provides growth with FX volatility.
The equity debate is on capital return sustainability and Asia growth trajectory.
Industry & Market Backdrop
The broader competitive and macro environment MET operates in — context a pure valuation table can't convey on its own.
Group Benefits market has been steady; employer-mandated coverage supports demand.
Pension Risk Transfer activity has been robust as corporations offload liabilities.
Interest rate environment has been a positive for spread businesses.
Asian markets provide growth but FX volatility is real.
Live Key Statistics
Pulled live from BriMindInvest's market-data pipeline at page load — the same feed that powers /analysis/MET. Fields the pipeline doesn't return this load are omitted rather than shown blank.
Business Overview
US Group Benefits: employer-provided life, disability, dental, and voluntary benefits.
RIS: pension risk transfer, retirement solutions, structured settlements.
Asia: life insurance in Japan, Korea, China, and other markets.
Latin America: life and pensions.
Segment Deep Dive
A closer look at each reporting segment individually, rather than treating the business as a single undifferentiated revenue line.
The most stable segment. Scale in distribution and underwriting is a durable moat.
PRT is a growing institutional market as corporations offload defined-benefit liabilities. MetLife is a top participant.
Japan is the largest and most stable market; Korea and China provide growth. FX adds volatility.
Capital Allocation & Balance Sheet Philosophy
How management has historically chosen to deploy cash — buybacks, dividends, R&D, and acquisitions — and what that reveals about capital discipline.
Dividend has grown consistently.
Buybacks are aggressive.
Excess capital return has been a management priority.
M&A has been selective.
Management & Governance
Leadership, incentive alignment, and governance structure — factors that shape execution risk independent of the underlying business model.
Leadership has been stable.
Board includes insurance and financial services expertise.
Governance disclosures are strong.
See exactly how we get MET's fair-value range
| Method | Relevance | Implied Value |
|---|---|---|
| Our DCF Model | High | |
| Our P/E Based | Medium | |
| Our Book Value Based | Medium | |
| Graham Number | Medium | |
| PEG Ratio Based | Low | |
| ROIC Based | Medium | |
| FCF Yield Based | High |
Forecast Revenue and Free Cash Flow
5-Year Monte Carlo Simulation
Included with a subscription or a one-time purchase of this MetLife report:
- Fair value from 7 methods, weighted by relevance to this business
- 5-year financial forecast and DCF/earnings sensitivity grids
- Decomposed AI Score, Monte Carlo simulation, and institutional/analyst data
$3.99 is less than one bad options trade — see the model before you commit real money. And it goes straight to the small team building this, not a hedge fund's marketing budget.
Bull Case vs. Bear Case
- Group Benefits stability.
- PRT activity supports RIS.
- Interest rate environment favorable.
- Consistent capital return.
- Life industry multiple compression.
- Asia FX volatility.
- Long-duration liability risk in stress scenarios.
Related Reports
In-depth reports for other names in MetLife's comparable set.
3 catalysts and 3 risks we're tracking for MET
| Catalyst | Expected Impact | Timeframe |
|---|---|---|
Included with a subscription or a one-time purchase of this MetLife report:
- Catalyst list, each tagged with expected impact and timing
- Risk register scored by probability and severity
- 4 key metrics to watch before the next earnings report
$3.99 is less than one bad options trade — see the model before you commit real money. And it goes straight to the small team building this, not a hedge fund's marketing budget.
What Would Change Our Mind?
Specific, falsifiable triggers — not vague sentiment — that would move us toward or away from the bull case above.
- PRT deal flow accelerates
- Asia growth exceeds guidance
- Capital return pace exceeds expectations
- Rate environment reverses sharply
- Asia FX volatility increases
- Investment portfolio credit stress emerges
Competitive Positioning
Group Benefits scale is a durable moat.
PRT capability is competitive with Prudential and other leaders.
Asia franchise is meaningful in scale.
Investor Decision Framework
A process for using this report, not a recommendation — how to weigh valuation, scenario spread, and your own risk tolerance.
- Own it as a diversified life insurer with disciplined capital return.
- Position size for FX and rate exposure.
The BriMindInvest Edge
Why this report is different from asking a general-purpose AI chatbot about the stock.
- Every valuation number on this page is computed live from current market data through our own DCF, scoring, and Monte Carlo engines — not summarized or paraphrased from other analysts' reports the way a general chatbot would.
- The relevance-weighted fair value, reverse-DCF market-implied growth, fundamentals-based Monte Carlo, and scenario tables above are proprietary calculations you cannot get by asking a general-purpose AI for "MET fair value" — those answers come from web summaries of other people's price targets, not a live, disclosed-assumption model.
- Our 1-year price-target model has a real, published backtest (see Model Track Record above where covered) — we show our work and our error rate rather than asserting accuracy.
- Numbers here are refreshed every time you load the page, not cached from a training cutoff months or years in the past.
Data Sources & Methodology
Valuation, price, and financial-statistics data in this report are fetched live from our production market-data pipeline (Yahoo Finance and Finnhub) at the time you loaded this page. The AI Score is a percentile ranking against our full covered stock universe, recomputed nightly. The fundamentals-based Monte Carlo and Bull/Base/Bear scenarios randomize growth rate, discount rate, and terminal growth around the same disclosed DCF assumptions used in the valuation table — they are not derived from resampled historical stock returns. The secondary historical-volatility simulation (2,000 bootstrap paths, seeded for reproducibility) uses the stock's own historical monthly returns and is shown separately because it measures a different thing (volatility) than the fundamentals-based model (intrinsic value).
This report is for informational and educational purposes only and does not constitute financial, investment, or tax advice, or a recommendation to buy or sell any security. All valuation models, price targets, and simulations are estimates based on historical and current data; actual results will differ, potentially substantially. Investing involves risk, including loss of principal. See our full Methodology and Disclaimer.
Free vs. Premium: What You're Getting
- Narrative overview and general bull/bear framing
- Headline price and basic company facts
- No live valuation model, AI Score, or forecast table
- Relevance-weighted fair value range and reverse-DCF market-implied growth
- 5-year financial forecast, DCF sensitivity grid, and Bull/Base/Bear scenario table
- Fundamentals-based Monte Carlo and decomposed AI Score with sub-factor components
- Real, published backtested accuracy where MET is in our coverage set
Glossary of Key Terms
Plain-English definitions for the terms used throughout this report, for readers newer to equity valuation.
Frequently Asked Questions
Unlock Full AI-Powered Analysis
Get AI prediction signals, unlimited stock comparisons, portfolio analytics, and personalized watchlists — free for 14 days, no credit card required.
14-day free trial · No credit card required · Cancel anytime
Not ready to sign up? Get one free email a week instead.